UPDATE 1-AstraZeneca sells two dermatology drug rights to LEO Pharma
July 01, 2016 at 03:17 AM EDT
July 1 (Reuters) - British drugmaker AstraZeneca Plc said it sold the rights to develop an experimental mid-stage drug to treat atopic dermatitis to privately-held LEO Pharma.
